News

Alejandro Burga, group leader at IMBA, and David Haselbach, Technology Platform Head for cryo electron microscopy at the IMP, were selected by the…

Paralogous proteins have evolved from gene or whole genome duplications and may provide an insurance policy for deleterious mutations. Why some…

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human…

Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation? Using…

The Vienna BioCenter (VBC) is delighted to announce that nine of its distinguished researchers have been named on the 2023 Clarivate list of the…

The Max Perutz PhD Fellowship honors the most ambitious and innovative PhD projects at the institute. This year’s awardees are Jeanne Fesselet…

Approximately one in eight men will be diagnosed with prostate cancer in his lifetime. Prostate cancer is commonly androgen addicted, in which case…

Valneva announced that the U.S. Food and Drug Administration (FDA) has approved IXCHIQ^®, Valneva’s single-dose, live-attenuated vaccine indicated for…

Swiss independent AVINA Stiftung has awarded one of its sought-after grants to Shaul Pollak, a group leader at the Division for Microbial Ecology at…